• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
#

Health

: 5
Ouras initial public offering could take place as early as next week, according to Reuters / Photo: Erman Gunes / Shutterstock
News·22.09.2026 11:23
The creator of Zuckerberg's favorite smart rings plans to go public with a valuation of $15.6 billion
Ouras revenue for the most recent reporting period totaled $1.21 billion, up 74% year-over-year; its main source of revenue is sales of smart rings, the company reported ahead of its IPO / Photo: Jerry Kavan / unsplash
News·04.09.2026 21:51
Oura, a manufacturer of smart rings, has filed for an IPO. It plans to list on the Nasdaq.
Oura is preparing for an IPO. One of its main risks is the potential loss of patent protection. Photo: Petr Urbanek / Unsplash
Review·07.08.2026 12:45
Oura, Zuckerberg and Kardashian’s “favorite” smart ring maker, goes public. Analysis
A generic price war could drop the cost of semaglutide in some countries to $15 for a monthly course / Photo: charlesdeluvio / Unsplash.com
Review·23.01.2026 12:30
Substance-for-money exchange: $32 billion semaglutide market enters patent collapse phase
  • LLY
  • NOVO-B.CO
  • DRREDDY.NS
  • SDZ.SW
  • +6
The $8 trillion market: whos going to capitalize on longevity
Review·15.06.2025 17:02
The $8 trillion market: who's going to capitalize on longevity
  • AAPL
  • GRMN
  • CHDRF
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026